Early Evidence of Impact of Monovalent Rotavirus Vaccine in Togo

Clinical Infectious Diseases

Volumn 62, Issue , 2016, Pages S196-S199

  Tsolenyanu, Enyonam ^a   Mwenda, Jason M ^b   Dagnra, Anoumou ^a   Leshem, Eyal ^c   Godonou, Mawussi ^a   Nassoury, Ibrahim ^d   Landoh, Dadja ^b   Tate, Jacqueline E ^c   Atakouma, Yawo ^a   Parashar, Umesh D ^c  

^a Sylvanus Olympio Teaching Hospital of Lome   (Togo)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^d Ministry of Health   (India)

Author keywords

impact; monovalent rotavirus vaccine; rotavirus; Togo

Indexed keywords

ROTAVIRUS VACCINE; LIVE VACCINE; RIX4414 VACCINE;

ACUTE GASTROENTERITIS; ARTICLE; CHILD; HOSPITALIZATION; HUMAN; IMMUNIZATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; ROTAVIRUS INFECTION; SEASONAL VARIATION; SENTINEL SURVEILLANCE; TOGO; ACUTE DISEASE; FEMALE; GASTROENTERITIS; IMMUNOLOGY; INFANT; MALE; PRESCHOOL CHILD; ROTAVIRUS; ROTAVIRUS INFECTIONS; SEASON; STATISTICS AND NUMERICAL DATA; VACCINATION; VIROLOGY;

ACUTE DISEASE; CHILD, PRESCHOOL; FEMALE; GASTROENTERITIS; HOSPITALIZATION; HUMANS; INFANT; MALE; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; SEASONS; TOGO; VACCINATION; VACCINES, ATTENUATED;

EID: 84965121930     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ1182     Document Type: Article

References (10)

1. Liu L, Johnson H, Cousens S, et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 2012; 379:2151-61.
2. Tate EJ, Burton HA, Boschi-Pinto C, et al. 2008 estimate of worldwide rotavirusassociated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programs: A systematic review and meta-analysis. Lancet 2012; 12:136-41.
3. Parashar UD, Burton A, Lanata C, et al. Global mortality associated with rotavirus disease among children in 2004. J Infect Dis 2009; 200(suppl 1):S9-15.
4. Curns AT, Steiner CA, Barrett M, et al. Reduction in acute gastroenteritis hospitalizations among US children after introduction of rotavirus vaccine: analysis of hospital discharge data from 18 US states. J Infect Dis 2010; 201:1617-24.
5. Lanzieri TM, Linhares AC, Costa I, et al. Impact of rotavirus vaccination on childhood deaths from diarrhea in Brazil. J Infect Dis 2011; 15:e206-10.
6. Bayard V, DeAntonio R, Contreras R, et al. Impact of rotavirus vaccination on childhood gastroenteritis-related mortality and hospital discharges in Panama. J Infect Dis 2012; 16:e94-8.
7. David RL, Kirk MD. Rotavirus gastroenteritis hospitalisations following introduction of vaccination, Canberra. Commun Dis Intell Q Rep 2014; 38:E3-8.
8. Armah GE, Sow SO, Breiman RF, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: A randomised, double-blind, placebo-controlled trial. Lancet 2010; 376:606-14.
9. Tsolenyanu E, Seheri M, Dagnra A, et al. Surveillance for rotavirus gastroenteritis in children less than 5 years of age in Togo. Pediatr Infect Dis J 2014; 33(suppl 1): S14-8.
10. World Health Organization. Generic protocol for (i) hospital-based surveillance to estimate the burden of rotavirus gastroenteritis in children and (ii) a communitybased survey on utilization of health care services for gastroenteritis in children, Field test version. Geneva, Switzerland: WHO, 2002. Available at: www.who.int/vaccines-documents/. Accessed 30 November 2015.